Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.720
+0.031 (4.50%)
At close: Nov 22, 2024, 4:00 PM
0.700
-0.020 (-2.74%)
After-hours: Nov 22, 2024, 5:26 PM EST
Predictive Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1.48 | 1.78 | 1.51 | 1.42 | 1.25 | 1.41 | Upgrade
|
| Revenue Growth (YoY) | -11.21% | 18.24% | 5.97% | 13.45% | -11.28% | -0.01% | Upgrade
|
| Cost of Revenue | 0.8 | 0.63 | 0.51 | 0.49 | 0.45 | 0.53 | Upgrade
|
| Gross Profit | 0.68 | 1.15 | 1 | 0.93 | 0.81 | 0.88 | Upgrade
|
| Selling, General & Admin | 14.32 | 15.07 | 16.27 | 14.41 | 13.29 | 14 | Upgrade
|
| Operating Expenses | 14.32 | 15.07 | 16.27 | 14.41 | 13.29 | 14 | Upgrade
|
| Operating Income | -13.64 | -13.92 | -15.27 | -13.47 | -12.48 | -13.12 | Upgrade
|
| Interest Expense | -0.05 | - | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.44 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | 0.1 | 0.31 | 0.12 | -0.36 | -3.18 | Upgrade
|
| EBT Excluding Unusual Items | -13.61 | -13.82 | -14.96 | -13.36 | -12.84 | -16.74 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.66 | Upgrade
|
| Impairment of Goodwill | - | - | -7.23 | -2.81 | -12.88 | -8.1 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 6.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | -0.01 | -0.01 | - | - | Upgrade
|
| Asset Writedown | -0.16 | -0.16 | -3.53 | -4.14 | - | -0.77 | Upgrade
|
| Other Unusual Items | 0.06 | - | - | - | -0.16 | 0.71 | Upgrade
|
| Pretax Income | -13.72 | -13.98 | -25.74 | -20.32 | -25.88 | -19.39 | Upgrade
|
| Income Tax Expense | - | - | - | -0.66 | - | - | Upgrade
|
| Net Income | -13.97 | -13.98 | -25.74 | -19.66 | -25.88 | -19.39 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.55 | 0.29 | Upgrade
|
| Net Income to Common | -13.97 | -13.98 | -25.74 | -19.66 | -26.44 | -19.68 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 4 | 3 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 4 | 3 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 20.51% | 8.92% | 34.34% | 359.21% | 316.36% | 123.95% | Upgrade
|
| EPS (Basic) | -2.91 | -3.48 | -6.98 | -7.16 | -44.25 | -137.14 | Upgrade
|
| EPS (Diluted) | -2.91 | -3.48 | -6.98 | -7.20 | -44.25 | -137.20 | Upgrade
|
| Free Cash Flow | -13.14 | -13.47 | -12.79 | -13.12 | -12.56 | -8.74 | Upgrade
|
| Free Cash Flow Per Share | -2.74 | -3.35 | -3.47 | -4.78 | -21.01 | -60.89 | Upgrade
|
| Gross Margin | 45.91% | 64.34% | 66.45% | 65.72% | 64.29% | 62.32% | Upgrade
|
| Operating Margin | -919.14% | -782.06% | -1014.16% | -948.25% | -996.87% | -929.31% | Upgrade
|
| Profit Margin | -941.24% | -785.58% | -1709.62% | -1383.65% | -2111.26% | -1394.25% | Upgrade
|
| Free Cash Flow Margin | -885.20% | -756.46% | -849.62% | -923.46% | -1002.67% | -619.05% | Upgrade
|
| EBITDA | -12.99 | -13.18 | -13.95 | -12.13 | -11.46 | -12.41 | Upgrade
|
| D&A For EBITDA | 0.65 | 0.74 | 1.31 | 1.34 | 1.02 | 0.7 | Upgrade
|
| EBIT | -13.64 | -13.92 | -15.27 | -13.47 | -12.48 | -13.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.